PA
GFF icon

PharVision Advisers’s Griffon GFF Stock Holding History

PharVision Advisers’s Portfolio GFF Stock Details GFF Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-6,307
Closed -$465K – 322
2025
Q4 		$465K Buy
+6,307
New +$469K 0.24% 56
2025
Q1 		– Sell
-3,631
Closed -$259K – 365
2024
Q4 		$259K Buy
+3,631
New +$263K 0.22% 205

Other funds holding GFF

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VC
Voss Capital Houston, Texas $1.88B AUM 1.03% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
NAMI
Nomura Asset Management International Philadelphia, Pennsylvania $58.4B AUM
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return

PharVision Advisers's GFF Position: Q1 2026 in Review

PharVision Advisers sold out of Griffon (GFF) in Q1 2026, closing a stake of 6,307 shares — an estimated $465K sold.

PharVision Advisers first reported a position in GFF in Q4 2024 and held it in 2 quarters. The position peaked at $465K in Q4 2025. 339 funds tracked by Wall St. Rank hold GFF as of Q1 2026.

  • PharVision Advisers reported no remaining Griffon position as of Q1 2026 after selling out during the quarter.
  • PharVision Advisers sold 6,307 Griffon shares in Q1 2026, an estimated $465K.
  • PharVision Advisers first reported a position in Griffon in Q4 2024 and held it in 2 quarters.
  • PharVision Advisers's Griffon position peaked at $465K in Q4 2025.
  • 339 funds tracked by Wall St. Rank held Griffon as of Q1 2026.

Based on PharVision Advisers's 13F filing for Q1 2026, filed 22 Apr 2026.